Highly specific for primary biliary cholangitis (PBC; formerly PBC). Positive in ~95% of PBC patients. The M2 subtype targets pyruvate dehydrogenase complex.
| Sex | Age | Range | Notes |
|---|---|---|---|
| All | ≥ 18 yrs | See notes | Positive (≥1:40) or Negative |
⚠ Clinical Note
Reference ranges are indicative. Always interpret results in the context of the individual patient and local laboratory reference intervals, which may vary.